HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS
- 1 July 1999
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 13 (11) , 1305-1311
- https://doi.org/10.1097/00002030-199907300-00006
Abstract
To assess syncytium-inducing (SI) and non-syncytium-inducing (NSI) frequencies, coreceptor usage and gp120 V3 sequences of HIV-1 isolates from Ethiopian AIDS patients. Cross-sectional study on 48 hospitalized AIDS patients (CD4 T cells <200¥106 cell/l) with stage III or IV of the WHO staging system for HIV-1 infection and disease. Peripheral blood mononuclear cells (PBMC) from all 48 patients were tested by MT-2 assay to determine SI/NSI phenotypes. Lymphocyte subsets were enumerated using Coulter counting and FACScan analysis. Viral load determination used a nucleic acid sequence-based amplification assay (NASBA). Coreceptor usage of HIV-1 biological clones was measured using U87 CD4/chemokine receptor transfectants and phytohemagglutinin-stimulated PBMC of healthy donors with wild-type CCR5 and homozygous mutation CCR5D32 (a 32 base-pair deletion in CCR5). Reverse transcriptase polymerase chain reaction sequencing was performed on the third variable region (V3) of the HIV-1 gene gp120. Sequence alignments were done manually; phylogenetic analyses used PHYLIP software packages. SI viruses were detected for 3/48 (6%) AIDS patients only. Lower mean absolute CD4 counts were determined in patients with SI virus compared with NSI (P=0.04), but no differences in viral load were observed. All patients were found to be infected with HIV-1 subtype C, based on V3 sequencing. NSI biological clones used CCR5 as coreceptor; SI biological clones used CXCR4 and/or CCR5 and/or CCR3. Ethiopian patients with HIV-1 C-subtype AIDS harbour a remarkably low frequency of SI phenotype viruses. Coreceptor usage of these viruses correlates with their biological phenotypes.Keywords
This publication has 38 references indexed in Scilit:
- HIV Type 1 Subtypes, Coreceptor Usage, and CCR5 PolymorphismAIDS Research and Human Retroviruses, 1997
- HIV Type 1 Subtype C in Addis Ababa, EthiopiaAIDS Research and Human Retroviruses, 1997
- STRL33, A Novel Chemokine Receptor–like Protein, Functions as a Fusion Cofactor for Both Macrophage-tropic and T Cell Line–tropic HIV-1The Journal of Experimental Medicine, 1997
- The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 IsolatesPublished by Elsevier ,1996
- A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion CofactorsCell, 1996
- A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variantsAIDS, 1995
- Correlation between Genetic and Biological Properties of Biologically Cloned HIV Type 1 Viruses Representing Subtypes A, B, and DAIDS Research and Human Retroviruses, 1995
- Rapid Grouping of HIV-1 Infection in Subtypes A to E by V3 Peptide Serotyping and Its Relation to Sequence AnalysisBiochemical and Biophysical Research Communications, 1994
- Syncytium-Inducing and Non-Syncytium-Inducing Capacity of Human Immunodeficiency Virus Type 1 Subtypes Other Than B: Phenotypic and Genotypic CharacteristicsAIDS Research and Human Retroviruses, 1994
- Sequence analysis of selected regions of theenv (V 3 loop and gp 41) andgag (p 7) reading frames of Ethiopian human immunodeficiency virus type 1 strainsArchiv für die gesamte Virusforschung, 1993